Robert A. Copeland
2013
In 2013, Robert A. Copeland earned a total compensation of $965.7K as President of Research and Chief Scientific Officer at Epizyme, a 75% increase compared to previous year.
Compensation breakdown
| Bonus | $139,280 |
|---|---|
| Option Awards | $473,666 |
| Salary | $348,201 |
| Other | $4,598 |
| Total | $965,745 |
Copeland received $473.7K in option awards, accounting for 49% of the total pay in 2013.
Copeland also received $139.3K in bonus, $348.2K in salary and $4.6K in other compensation.
Rankings
In 2013, Robert A. Copeland's compensation ranked 6,784th out of 12,286 executives tracked by ExecPay. In other words, Copeland earned more than 44.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,784 out of 12,286 | 45th |
Division Manufacturing | 2,397 out of 4,612 | 48th |
Major group Chemicals And Allied Products | 721 out of 1,462 | 51st |
Industry group Drugs | 529 out of 1,156 | 54th |
Industry Pharmaceutical Preparations | 421 out of 890 | 53rd |
Source: SEC filing on April 15, 2015.
Copeland's colleagues
We found three more compensation records of executives who worked with Robert A. Copeland at Epizyme in 2013.